Literature DB >> 5348475

Cephalexin: human studies of absorption and excretion of a new cephalosporin antibiotic.

P E Gower, C H Dash.   

Abstract

1. Serum levels, half-lives and urine concentrations of cephalexin, an oral cephalosporin antibiotic which is unique in its absorption and excretion, are reported in human volunteers, fasting, non-fasting and non-fasting plus probenecid. Accumulation does not seem to occur.2. Cephalexin clearance was 376 ml./min and the ratio of cephalexin/creatinine clearances was 2.6 in one volunteer.3. Cephalexin had no effect on the urinary excretion of leucocytes, red cells or protein.4. The very high rate of absorption giving high serum levels and urine concentrations suggest cephalexin will be a useful antibiotic in susceptible bacterial infections in man.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5348475      PMCID: PMC1703714          DOI: 10.1111/j.1476-5381.1969.tb08513.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  Cephaloridine: antimicrobial activity and pharmacologic behavior.

Authors:  K Kaplan; B E Reisberg; L Weinstein
Journal:  Am J Med Sci       Date:  1967-06       Impact factor: 2.378

2.  Cephaloridine: pharmacology and toxicology.

Authors:  J P Currie
Journal:  Postgrad Med J       Date:  1967-08       Impact factor: 2.401

Review 3.  The tetracyclines. A critical reappraisal.

Authors:  M M Mull
Journal:  Am J Dis Child       Date:  1966-11

Review 4.  Complications of tetracycline therapy.

Authors:  C A Olson; H D Riley
Journal:  J Pediatr       Date:  1966-05       Impact factor: 4.406

5.  Laboratory and clinical evaluation of cephaloridine in 78 patients.

Authors:  P G Cohen; M J Romansky; A C Johnson
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

6.  Clinical evaluation of cephaloridine.

Authors:  M Dennis; J R Rasch; H K Hastings
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

7.  A guide to use of antibiotics in patients with renal disease. A table of recommended doses and factors governing serum levels.

Authors:  C M Kunin
Journal:  Ann Intern Med       Date:  1967-07       Impact factor: 25.391

8.  Cephaloridine therapy as related to renal function.

Authors:  S A Kabins; S Cohen
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

9.  Bacteriological and pharmacological properties of cephalothin and cephaloridine.

Authors:  P Naumann
Journal:  Postgrad Med J       Date:  1967-08       Impact factor: 2.401

10.  Cephalexin, a new orally absorbed cephalosporin antibiotic.

Authors:  W E Wick
Journal:  Appl Microbiol       Date:  1967-07
View more
  12 in total

Review 1.  Food-drug interactions.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Drug interactions at the renal level. Implications for drug development.

Authors:  P L Bonate; K Reith; S Weir
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

Review 3.  Cephalexin: a review of its antibacterial, pharmacological and therapeutic properties.

Authors:  T M Speight; R N Brogden; G S Avery
Journal:  Drugs       Date:  1972       Impact factor: 9.546

4.  Gut flora after cephalexin.

Authors:  C N Brown; G E Mallett
Journal:  Br Med J       Date:  1970-10-10

5.  Comparative double-blind study of cephalexin and co-trimoxazole in urinary tract infections.

Authors:  P E Gower; P R Tasker
Journal:  Br Med J       Date:  1976-03-20

Review 6.  Cephalosporin-probenecid drug interactions.

Authors:  G R Brown
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

7.  Comparative double-blind trial of cephalexin and ampicillin in treatment of urinary infections.

Authors:  J A Davies; J E Strangeways; R G Mitchell; L J Beilin; J G Ledingham; J M Holt
Journal:  Br Med J       Date:  1971-07-24

8.  Pharmacokinetics of alafosfalin, alone and in combination with cephalexin, in humans.

Authors:  J G Allen; L J Lees
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

9.  Changes in gut flora after cephalexin treatment.

Authors:  H Gaya; P I Adnitt; P Turner
Journal:  Br Med J       Date:  1970-09-12

10.  Clinical pharmacology of cephalexin administered by intravenous injection.

Authors:  J A Davies; J M Holt
Journal:  J Clin Pathol       Date:  1972-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.